Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover how metal-free amide synthesis reduces production costs and safety risks for pharmaceutical intermediates. Scale-ready, high-yield process with 99% purity. Contact us for custom synthesis solutions.
Discover how emerging bimatoprost synthesis methods reduce costs by 25% with 85%+ yields. Solve supply chain risks for glaucoma treatments and eyelash growth applications.
Discover how iodine-catalyzed synthesis of imidazo[1,2-a]pyridine achieves 86% yield, eliminates heavy metals, and reduces purification costs for pharmaceutical intermediates.
Discover how cobalt-catalyzed C-H activation enables cost-effective 1H-indole-2-amide production for MAO-A inhibitors and NMDA antagonists. Reduce supply chain risks with scalable chemistry.
Discover iodine-catalyzed imidazo[1,2-a]pyridine synthesis with 86% yield, eliminating heavy metals and reducing purification costs for pharmaceutical production.
Solve N-acyl indole synthesis challenges with high-yield, functional-group-tolerant process. Reduce costs and safety risks in API manufacturing.
Discover a novel palladium-catalyzed method for direct construction of two connected tertiary carbon bonds with high yield and optical purity. Ideal for pharmaceutical and fine chemical manufacturing.
Avoid toxic reagents in (S)-4-phenyl-2-oxazolidinone production. New borane-based route offers 99% purity, 70% yield, and GMP-compliant scalability for API manufacturing.
Discover how iron-catalyzed cyclopropyl borate synthesis reduces costs and environmental risks for pharmaceutical intermediates. Scale with NINGBO INNO PHARMCHEM.
Discover a novel one-step synthesis for pyrazolo[3,4-d]pyrimidin-4(5H)-one with 56-62% yield. Eliminate multi-step intermediates and reduce production costs for your API development.
High-yield Pd-catalyzed route for 2,3-dihydroquinolone intermediates with 59-88% yields. Ideal for anti-cancer/analgesic drug development. Scale to 100 MT/yr.
Solve β-halopyrrole synthesis challenges with novel palladium-catalyzed method. Achieve 40-62% yields, broad substrate scope, and safe operation for API manufacturing.
Discover how iron-catalyzed pyrrole synthesis reduces costs by 70% vs. noble metals, with high yields (80-90%) and simplified purification for your API production.
Discover a cost-effective, metal-free synthesis method for trifluoromethyl-1,2,4-triazine compounds. Achieve 65-87% yields in air without heavy catalysts. Ideal for pharmaceutical intermediates.
Discover how biocatalytic synthesis of chiral pseudonucleosides offers superior enantioselectivity, reduced waste, and cost-effective production for your antiviral and antitumor drug development.
Solve supply chain risks with this one-step quinoline-4(1H)-one synthesis. Avoid high-pressure CO, achieve >99% purity, and reduce production costs for your API development.
Discover efficient benzocycloheptenone synthesis with rhodium catalysis. Reduce costs, improve yields, and ensure supply chain stability for pharmaceutical intermediates.
Solve supply chain risks with this anhydrous-free 1,2,4-triazolyl arylamine synthesis. Cheap starting materials, high yields, and scalable to 100MT/yr for drug development.
Solve supply chain risks with one-step palladium-catalyzed carbonylation. 80-95% yield, no anhydrous conditions. Contact for custom synthesis.
Solve toxic CO gas risks in biheterocyclic synthesis. Our CDMO expertise enables scalable, high-purity production for drug development. Contact for COA/MSDS.